David Lloyd

Title: David Lloyd: Innovator in Nucleic Acid Detection

Introduction

David Lloyd is a prominent inventor based in Abingdon, GB. He has made significant contributions to the field of nucleic acid detection, holding a total of 3 patents. His work focuses on developing methods and devices that enhance the accuracy and efficiency of nucleic acid detection.

Latest Patents

One of David Lloyd's latest patents is a method for nucleic acid detection that relates to the detection of nucleic acids of defined sequence. This invention includes kits and devices designed for use in these methods. The techniques utilize restriction enzymes, polymerase, and oligonucleotide primers to generate an amplification product in the presence of a target nucleic acid. This target is then contacted with oligonucleotide probes to yield a detector product. Another patent also focuses on nucleic acid detection methods, employing nicking agents, polymerase, and oligonucleotide probes to create probe fragments in the presence of a target nucleic acid.

Career Highlights

David Lloyd is currently associated with Sense Biodetection Limited, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the methodologies used for nucleic acid detection, which has important implications in various scientific and medical applications.

Collaborations

David has collaborated with notable colleagues, including Henry John Lamble and Christopher Egan. These partnerships have contributed to the development of cutting-edge technologies in the field.

Conclusion

David Lloyd's contributions to nucleic acid detection exemplify the impact of innovative thinking in biotechnology. His patents and ongoing work at Sense Biodetection Limited continue to push the boundaries of what is possible in this critical area of research.